FreeGulliver LLC’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$275K Sell
3,888
-460
-11% -$34.4K 0.12% 79
2025
Q4
$343K Buy
4,348
+13
+0.3% +$1.03K 0.13% 63
2025
Q3
$357K Buy
4,335
+462
+12% +$36.4K 0.16% 63
2025
Q2
$311K Sell
3,873
-6
-0.2% -$463 0.14% 62
2025
Q1
$311K Buy
3,879
+23
+0.6% +$1.91K 0.15% 63
2024
Q4
$316K Sell
3,856
-93
-2% -$7.74K 0.15% 59
2024
Q3
$326K Buy
3,949
+93
+2% +$6.95K 0.19% 52
2024
Q2
$271K Hold
3,856
0.19% 57
2024
Q1
$286K Hold
3,856
0.25% 44
2023
Q4
$255K Buy
+3,856
New +$241K 0.34% 32

Other funds holding MET

FreeGulliver LLC's MET Position: Q1 2026 in Review

FreeGulliver LLC reduced its MetLife (MET) stake by 11% in Q1 2026, selling an estimated $34.4K and leaving 3,888 shares worth $275K. The position accounts for 0.12% of the portfolio, ranked #79.

FreeGulliver LLC first reported a position in MET in Q4 2023 and has held it in 10 quarters since. The position peaked at $357K in Q3 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • FreeGulliver LLC held 3,888 shares of MetLife worth $275K as of Q1 2026.
  • FreeGulliver LLC sold 460 MetLife shares in Q1 2026, an estimated $34.4K.
  • MetLife made up 0.12% of FreeGulliver LLC's portfolio in Q1 2026, its #79 holding.
  • FreeGulliver LLC first reported a position in MetLife in Q4 2023 and has held it in 10 quarters since.
  • FreeGulliver LLC's MetLife position peaked at $357K in Q3 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on FreeGulliver LLC's 13F filing for Q1 2026, filed 15 May 2026.